RPG LifeScience.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE105J01010
NSEID: RPGLIFE
BSEID: 532983
View on NSE | View on BSE

INR

2,658.35

-30.2 (-1.12%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 9.33 k

{
  "main_header": {
    "sid": 456242,
    "name": "RPG LifeScience.",
    "stock_name": "RPG LifeScience.",
    "full_name": "RPG Life Sciences Ltd",
    "name_url": "stocks-analysis/rpg-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,658.35",
    "chg": -30.2,
    "chgp": "-1.12%",
    "dir": -1,
    "prev_price": "2,688.55",
    "mcapval": "4,399.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532983,
    "symbol": "RPGLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE105J01010",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "17:55 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "9.33 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rpg-lifescience-456242-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "RPG Life Sciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-4134520",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/RPGLifeSciences_technicaldot_4134520.png",
        "date": "2026-08-04 08:04:08",
        "description": "RPG Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to signal underlying strength, while others like Dow Theory and KST present a more cautious outlook. This article analyses the recent technical developments, price action, and comparative returns to provide a comprehensive view for investors."
      },
      {
        "title": "RPG Life Sciences Falls 5.01% Despite Strong Quarterly Turnaround: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-falls-501-despite-strong-quarterly-turnaround-3-key-factors-driving-the-week-4131958",
        "imagepath": "",
        "date": "2026-08-01 17:11:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at Rs.2,918.55, modest gain of 0.19%</p>\n                    <p><strong>28 Jul:</strong> Price dips 1.28% amid broader market weakness</p>\n                    <p><strong>29 Jul:</strong> Strong quarterly results announced; stock falls 1.19%</p>\n                    <p><strong>30 Jul:</strong> Continued decline of 2.43% despite Sensex gains</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.2,767.15, down 0.38%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,913.00</div></div>\n                    <div class..."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4128622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_mojoScore_4128622.png",
        "date": "2026-07-30 10:10:03",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Are RPG Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rpg-life-sciences-ltd-latest-results-good-or-bad-4127135",
        "imagepath": "",
        "date": "2026-07-29 19:19:16",
        "description": "RPG Life Sciences Ltd reported its financial results for Q1 FY27, showcasing a notable performance characterized by several key metrics. The company achieved net sales of ₹195.69 crores, reflecting a year-over-year revenue growth of 15.85% and a sequential growth of 10.63% from the previous quarter. This marks an all-time high in net sales, indicating a strengthening position in both domestic and export markets, supported by a diversified product portfolio that includes formulations and APIs.\n\nThe net profit for the quarter stood at ₹30.76 crores, which represents a year-over-year increase of 17.00%. However, the sequential growth was more modest at 2.88%, highlighting a slight deceleration compared to the previous quarter's performance. The operating margin improved to 22.12%, the highest in seven quarters, reflecting effective cost management and operational efficiency. The return on equity was reported a..."
      },
      {
        "title": "RPG Life Sciences Ltd Reports Strong Quarterly Financial Turnaround",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-reports-strong-quarterly-financial-turnaround-4125934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_fintrenddot_4125934.png",
        "date": "2026-07-29 11:00:11",
        "description": "RPG Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, signalling a positive shift from a previously flat trend. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics including net sales, profit after tax, and operating margins, reflecting robust operational execution and strategic momentum."
      },
      {
        "title": "RPG Life Sciences Q1 FY27: Robust Revenue Growth Drives Profit Surge Despite Premium Valuation",
        "link": "https://www.marketsmojo.com/news/result-analysis/rpg-life-sciences-q1-fy27-robust-revenue-growth-drives-profit-surge-despite-premium-valuation-4125961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_quaterlyResult_4125961.png",
        "date": "2026-07-29 09:47:09",
        "description": "RPG Life Sciences Ltd., a mid-sized pharmaceutical manufacturer specialising in formulations and active pharmaceutical ingredients, delivered a strong performance in Q1 FY27, with net profit climbing 17.00% year-on-year to ₹30.76 crores. The Mumbai-based company, valued at ₹4,687.24 crores, demonstrated resilience with revenue growth accelerating to 15.85% YoY whilst maintaining healthy operating margins above 22%. The stock has responded positively to sustained operational momentum, though investors remain cautious about the company's premium valuation of 44 times trailing earnings."
      },
      {
        "title": "RPG Life Sciences Gains 2.38%: 6 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-gains-238-6-key-factors-driving-the-weeks-volatility-4121315",
        "imagepath": "",
        "date": "2026-07-26 12:01:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> New 52-week and all-time high intraday peaks above Rs.3,040</p>\n                    <p><strong>21 Jul:</strong> Stock gaps down 6.03% but hits new 52-week high of Rs.3,080.90 intraday</p>\n                    <p><strong>22 Jul:</strong> Moderate recovery with 1.31% gain amid Sensex decline</p>\n                    <p><strong>23 Jul:</strong> Sharp 3.43% decline on low volume</p>\n                    <p><strong>24 Jul:</strong> Slight rebound of 0.37% closes the week at Rs.2,913</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,845.30</div><..."
      },
      {
        "title": "When is the next results date for RPG Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rpg-life-sciences-ltd-4116726",
        "imagepath": "",
        "date": "2026-07-22 23:17:22",
        "description": "The next results date for RPG Life Sciences Ltd is scheduled for July 28, 2026...."
      },
      {
        "title": "RPG Life Sciences Ltd Opens 6.03% Lower in Sharp Gap Down as Technicals Point to Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-opens-with-significant-gap-down-amid-market-concerns-4112714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_gapdown_4112714.png",
        "date": "2026-07-21 13:00:33",
        "description": ""
      }
    ],
    "total": 411,
    "sid": "456242",
    "stock_news_url": "https://www.marketsmojo.com/news/rpg-life-sciences-456242"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Jul-2026",
      "details": "Intimation on superannuation of Senior Management Personnel",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jul-2026",
      "details": "Newspaper advertisement in respect to Special window opened for lodgement of transfer and dematerialization request(s).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
      "datetime": "29-Jul-2026",
      "details": "Execution of Business Transfer Agreement",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "RPG Life Sciences Ltd has declared <strong>300%</strong> dividend, ex-date: 09 Jul 26",
          "dt": "2026-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

RPG Life Sciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-08-04 08:04:08

RPG Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to signal underlying strength, while others like Dow Theory and KST present a more cautious outlook. This article analyses the recent technical developments, price action, and comparative returns to provide a comprehensive view for investors.

Read full news article

RPG Life Sciences Falls 5.01% Despite Strong Quarterly Turnaround: 3 Key Factors Driving the Week

2026-08-01 17:11:32

Key Events This Week

27 Jul: Stock opens at Rs.2,918.55, modest gain of 0.19%

28 Jul: Price dips 1.28% amid broader market weakness

29 Jul: Strong quarterly results announced; stock falls 1.19%

30 Jul: Continued decline of 2.43% despite Sensex gains

31 Jul: Week closes at Rs.2,767.15, down 0.38%

Week Open

Rs.2,913.00

Read full news article

RPG Life Sciences Ltd is Rated Hold

2026-07-30 10:10:03

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Are RPG Life Sciences Ltd latest results good or bad?

2026-07-29 19:19:16

RPG Life Sciences Ltd reported its financial results for Q1 FY27, showcasing a notable performance characterized by several key metrics. The company achieved net sales of ₹195.69 crores, reflecting a year-over-year revenue growth of 15.85% and a sequential growth of 10.63% from the previous quarter. This marks an all-time high in net sales, indicating a strengthening position in both domestic and export markets, supported by a diversified product portfolio that includes formulations and APIs. The net profit for the quarter stood at ₹30.76 crores, which represents a year-over-year increase of 17.00%. However, the sequential growth was more modest at 2.88%, highlighting a slight deceleration compared to the previous quarter's performance. The operating margin improved to 22.12%, the highest in seven quarters, reflecting effective cost management and operational efficiency. The return on equity was reported a...

Read full news article

RPG Life Sciences Ltd Reports Strong Quarterly Financial Turnaround

2026-07-29 11:00:11

RPG Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, signalling a positive shift from a previously flat trend. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics including net sales, profit after tax, and operating margins, reflecting robust operational execution and strategic momentum.

Read full news article

RPG Life Sciences Q1 FY27: Robust Revenue Growth Drives Profit Surge Despite Premium Valuation

2026-07-29 09:47:09

RPG Life Sciences Ltd., a mid-sized pharmaceutical manufacturer specialising in formulations and active pharmaceutical ingredients, delivered a strong performance in Q1 FY27, with net profit climbing 17.00% year-on-year to ₹30.76 crores. The Mumbai-based company, valued at ₹4,687.24 crores, demonstrated resilience with revenue growth accelerating to 15.85% YoY whilst maintaining healthy operating margins above 22%. The stock has responded positively to sustained operational momentum, though investors remain cautious about the company's premium valuation of 44 times trailing earnings.